Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:16 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 21,027 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Cancer
Interventions: Telephone Intervention, Questionnaires & Interviews; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Non Small Cell Lung Cancer
Interventions: Nivolumab, 3D-EX, Evaluation of Response by RECIST; Drug · Diagnostic Test · Other
Lead sponsor: Nilogen Oncosystems; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Cannabis, Pain, Tolerance, Hyperalgesia
Interventions: Active Cannabis, Placebo Cannabis; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 60 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Vaccination, Vaccination Promotion
Interventions: Exposure to source and message content; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Common Bile Duct Stricture
Interventions: Fully covered Metallic Stent, Plastic Stent; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 7
States / cities: Chicago, Illinois • Indianapolis, Indiana • Ann Arbor, Michigan + 4 more

Conditions: Keratosis, Actinic
Interventions: Swift System; Device
Lead sponsor: Blackwell Device Consulting; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Angina, Unstable, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Myocardial Infarction, Heart Failure, Congestive
Interventions: GIK, Placebo; Drug
Lead sponsor: Tufts Medical Center; Other
Eligibility: 30 Years and older
Enrollment: 911 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 13
States / cities: Anchorage, Alaska • New Haven, Connecticut • Macon, Georgia + 10 more

Conditions: Happiness
Interventions: ENHANCE: Enduring Happiness and Continued Self-Enhancement; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 25 Years to 75 Years
Enrollment: 154 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Stress Disorders, Post-Traumatic
Interventions: Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR); Other
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Healthy Adult
Interventions: Unilateral Left tVNS stimulation, Bilateral tVNS stimulation, Unilateral Left Sham stimulation, Bilateral Sham stimulation, Unilateral Right tVNS stimulation, Unilateral Right Sham stimulation; Procedure
Lead sponsor: Georgia Institute of Technology; Other
Eligibility: 18 Years to 89 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Snoring
Interventions: DryMouth Shield; Device
Lead sponsor: VMS Medical Products, Inc; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Huntersville, North Carolina

Conditions: Non-small Cell Lung Cancer, Vomiting, Nausea, Emesis
Interventions: FOSAPREPITANT (Emend), Placebo; Drug
Lead sponsor: Ajeet Gajra; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Acute Leukemia
Interventions: Exercise; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Herpes Zoster, Herpes Zoster Vaccine
Interventions: Herpes Zoster vaccine GSK 1437173A, Licensed pneumococcal polysaccharide conjugate vaccine (23-valent, adsorbed), Pneumovax 23™; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 50 Years and older
Enrollment: 865 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Golden, Colorado • Wichita, Kansas • Columbia, Maryland

Conditions: Obesity
Interventions: Monlunabant, Placebo (monlunabant); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Cypress, California

Conditions: Posttraumatic Stress Disorder, PTSD
Interventions: Trauma Affect Regulation: Guide for Education and Therapy, Present Centered Therapy (PCT) - psychotherapy, No-treatment "waitlist" group; Behavioral · Other
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 2
States / cities: Farmington, Connecticut • Hartford, Connecticut

Conditions: Healthy
Interventions: DormoTech Vlab SpO2 sensor; Device
Lead sponsor: Dormotech Medical; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Parkinson's Disease (PD), Essential Tremor
Interventions: Phoneme sequence learning, Cessation and re-enabling of stimulation of the STN, Cessation and re-enabling of stimulation of the VIM thalamic nucleus, Multisyllabic sequence learning; Behavioral · Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Hyper-LDL-cholesterolemia, Metabolic Syndrome
Interventions: strawberries, Control powder; Dietary Supplement · Other
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Las Vegas, Nevada • Oklahoma City, Oklahoma • Stillwater, Oklahoma

Conditions: Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1), Atypical Neurofibroma
Interventions: APG-115, Selumetinib; Drug
Lead sponsor: AeRang Kim; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Dallas, Texas

Conditions: COVID-19, Vaccination Hesitancy, Health Misinformation, Communication
Interventions: Gamified misinformation refutation quiz, Refutational text blog post (active control); Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 4,071 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Stress, Psychological, Post-Traumatic Stress Disorder, Major Injury
Interventions: DEF-only, DEF + COPE; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Up to 5 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)
Interventions: Milk thistle (MT), Placebo, Lifestyle Modification, Fibroscan; Drug · Behavioral · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 9 Years to 22 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Skin Rejuvenation, Skin Quality, Wrinkle, Nasolabial Fold
Interventions: PRFM injection, Saline injection; Procedure
Lead sponsor: New York Medical College; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Valhalla, New York

Search by objective public record fields.

Identification and Treatment of Depression

Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

ARISe at UMass Chan

Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures

Microwave Treatment for Actinic Keratosis

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.

Enduring Happiness and Continued Self-Enhancement

Computer Monitor vs Augmented Reality 3MDR for PTSD PTSD: A Randomized Controlled Trial

tVNS Responsiveness Testing With Pupil Size

The Effect of the DryMouth Shield on Snoring

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

Exercise and Quality of Life in Leukemia Patients

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Mothers Overcoming and Managing Stress

The Accuracy of the Dormotech VLAB During Stable Hypoxia Plateaus

Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients

The Effects of Strawberries on Blood Cholesterol.

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

An Online Game to Help Canadian Adults Identify COVID-19 Vaccine Misinformation With One-Month Follow-Up

Intervention to Reduce Stress in 0-5 Year Olds With Burns

Milk Thistle Clinical Trial in Pediatric NAFLD

The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation